Page last updated: 2024-09-05
lu 135252 and a 192621
lu 135252 has been researched along with a 192621 in 1 studies
Compound Research Comparison
| Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) | Studies (a 192621) | Trials (a 192621) | Recent Studies (post-2010) (a 192621) |
|---|---|---|---|---|---|
| 196 | 13 | 14 | 84 | 0 | 8 |
Protein Interaction Comparison
| Protein | Taxonomy | lu 135252 (IC50) | a 192621 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.0051 | |
| Endothelin-1 receptor | Homo sapiens (human) | 9.05 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Buhr, HJ; Eibl, G; Foitzik, T; Forgacs, B; Hotz, HG | 1 |
Other Studies
1 other study(ies) available for lu 135252 and a 192621
| Article | Year |
|---|---|
Endothelin A but not endothelin B receptor blockade reduces capillary permeability in severe experimental pancreatitis.
Topics: Acute Disease; Animals; Blood Flow Velocity; Capillary Permeability; Colon; Endothelin Receptor Antagonists; Male; Pancreas; Pancreatitis; Phenylpropionates; Pyrimidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B | 2002 |